Fiducian rejects APRA concerns, says processes blocked Shield and First Guardian
Fiducian says its investment governance framework has avoided high-risk products like Shield and First Guardian from creeping onto the platform, rejecting concerns from APRA which added license restrictions on Fiducian after a thematic review found deficiencies in its oversight of investment options.
April 01, 2026


Compliance